Nisa Investment Advisors
JBIO

Nisa Investment Advisors’s Jade Biosciences JBIO Stock Holding History

Nisa Investment Advisors’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.3K Buy
1,371
+900
+191% +$13K ﹤0.01% 2028
2025
Q4 		$7.27K Buy
471
+428
+995% +$5.02K ﹤0.01% 2354
2025
Q3 		$371 Buy
+43
New +$351 ﹤0.01% 2889
2025
Q2 		– Sell
-25
Closed -$2.18K – 3040
2025
Q1 		$2.18K Hold
25
– – ﹤0.01% 2449
2024
Q4 		$2.3K Buy
25
+19
+317% +$1.64K ﹤0.01% 2447
2024
Q3 		$418 Buy
6
+5
+500% +$323 ﹤0.01% 2751
2024
Q2 		$37 Buy
+1
New +$663 ﹤0.01% 2913
2024
Q1 		– Hold
0
– – – 2637
2023
Q3 		– Hold
0
– -$120 – 2778
2023
Q2 		– Hold
0
– – – 2759
2023
Q1 		– Hold
0
– – – 2530
2022
Q4 		– Hold
0
– – – 2580

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Nisa Investment Advisors's JBIO Position: Q1 2026 in Review

Nisa Investment Advisors increased its Jade Biosciences (JBIO) stake by 191% in Q1 2026, buying an estimated $13K and bringing the position to 1,371 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2028.

Nisa Investment Advisors first reported a position in JBIO in Q2 2024 and has held it in 7 quarters since. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Nisa Investment Advisors held 1,371 shares of Jade Biosciences worth $19.3K as of Q1 2026.
  • Nisa Investment Advisors bought 900 Jade Biosciences shares in Q1 2026, an estimated $13K.
  • Jade Biosciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2028 holding.
  • Nisa Investment Advisors first reported a position in Jade Biosciences in Q2 2024 and has held it in 7 quarters since.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.